Dr. Sarju S. Patel, MD, MS

Dr. Patel practices at Retinal Consultants Medical Group in Sacramento, California.

Dr. Patel's NPI, 1730384876, was assigned on June 19, 2007. Dr. Patel graduated from Icahn School of Medicine at Mount Sinai in 2006. Dr. Patel holds California license C146195.

Dr. Patel's primary practice is Retinal Consultants Medical Group, at 3 Park Center Dr, Sacramento, CA 95825 in Sacramento County. The practice phone is (916) 596-2027.

Dr. Patel's primary practice is Retinal Consultants Medical Group in Sacramento, California. Dr. Patel is also affiliated with Dignity Health - Mercy General Hospital. Dmand AI also links Dr. Patel to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Patel practices, 3 sites in all. Vendor and product names are available with a free account.

Uveitis and ocular inflammatory disease is Dr. Patel's primary specialty in the NPI Registry, under taxonomy code 207WX0108X. Dmand AI has Dr. Patel's licenses on file in 2 states: California and Illinois.

CMS data shows 70,502 Medicare services from Dr. Patel across 32 procedure codes in 2024, for 1,621 Medicare patients. Medicare paid $6,282,300 for them.

CMS counts 1,621 Medicare patients who saw Dr. Patel in 2024. The largest group is 75 to 84, with 577 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Patel's median patient age at 71, with 57% women.

In 2024, Dr. Patel wrote 1,447 Medicare Part D claims for 437 patients. 72% of them were for generic drugs. CMS names the drug for 1,341 of them, across 18 drugs with 11 or more claims each, at $134,630 in total drug cost. In 2023, CMS named 1,355 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Patel for performance year 2024, reported as part of a group. Dr. Patel accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 15 papers to Dr. Patel, published from 2011 to 2018. 2013 was the busiest year, with 2. The most frequent topics are Cytomegalovirus Retinitis, Immunosuppressive Agents and Uveitis. Dr. Patel has published most often in Neurology. Dr. Patel's most frequent co-authors are Debra A. Goldstein, MD, Howard Harvey Tessler, MD and Mrinali Patel Gupta, MD.

CMS Open Payments shows 441 general payments to Dr. Patel from 29 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 55% of the total. Abbvie Inc. paid the most, $104,327.

Dr. Patel graduated from Icahn School of Medicine at Mount Sinai in 2006.